We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
-5.81%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$294M
AUM Growth
-$15.2M
Cap. Flow
+$5.08M
Cap. Flow %
1.73%
Top 10 Hldgs %
26.89%
Holding
106
New
Increased
46
Reduced
19
Closed
4

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$857K
2
MGA icon
Magna International
MGA
+$694K
3
BNY
Bank of New York Mellon
BNY
+$637K
4
AMZN icon
Amazon
AMZN
+$446K
5
DIS icon
Walt Disney
DIS
+$443K

Sector Composition

Rank Sector Weight
1 Healthcare 15.03%
2 Technology 12.65%
3 Industrials 11.7%
4 Consumer Staples 11.3%
5 Consumer Discretionary 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QRVO icon
51
Qorvo
QRVO
$8.43B
$2.36M 0.81%
29,775
+265
+0.9% +$25.6K
VTI icon
52
Vanguard Morningstar Total Stock Market ETF
VTI
$684B
$2.22M 0.76%
12,380
-22
-0.2% -$4.38K
MGA icon
53
Magna International
MGA
$18.7B
$2.2M 0.75%
46,440
+11,915
+35% +$694K
CTAS icon
54
Cintas
CTAS
$81.5B
$2.15M 0.73%
22,120
IJH icon
55
iShares Core S&P Mid-Cap ETF
IJH
$126B
$2.1M 0.71%
47,800
-1,295
-3% -$62.6K
HYG icon
56
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$2.01M 0.68%
28,129
+3,587
+15% +$271K
VB icon
57
Vanguard Morningstar Small-Cap ETF
VB
$82.3B
$1.98M 0.68%
11,611
+419
+4% +$79.1K
IBB icon
58
iShares Biotechnology ETF
IBB
$9.37B
$1.95M 0.67%
16,701
+585
+4% +$72.6K
BBH icon
59
VanEck Biotech ETF
BBH
$403M
$1.8M 0.61%
12,761
+280
+2% +$42.3K
USB icon
60
US Bancorp
USB
$101B
$1.73M 0.59%
42,931
-1,360
-3% -$62.9K
IAU icon
61
iShares Gold Trust
IAU
$63.4B
$1.7M 0.58%
53,838
JNJ icon
62
Johnson & Johnson
JNJ
$612B
$1.6M 0.54%
9,773
HYD icon
63
VanEck High Yield Muni ETF
HYD
$4.44B
$1.56M 0.53%
31,363
-7,675
-20% -$409K
LLY icon
64
Eli Lilly
LLY
$991B
$1.45M 0.49%
4,473
CVX icon
65
Chevron
CVX
$380B
$1.3M 0.44%
9,063
GOOG icon
66
Alphabet (Google) Class C
GOOG
$4.61T
$1.13M 0.39%
11,780
PFE icon
67
Pfizer
PFE
$145B
$1.04M 0.36%
23,832
WU icon
68
Western Union
WU
$2.27B
$968K 0.33%
71,747
-48,075
-40% -$753K
VEU icon
69
Vanguard FTSE All-World ex-US ETF
VEU
$68.1B
$933K 0.32%
21,034
+365
+2% +$18.1K
SYK icon
70
Stryker
SYK
$129B
$881K 0.3%
4,354
PAYX icon
71
Paychex
PAYX
$41.9B
$861K 0.29%
7,675
VEA icon
72
Vanguard FTSE Developed Markets ETF
VEA
$234B
$798K 0.27%
21,965
+8,022
+58% +$327K
PFF icon
73
iShares Preferred and Income Securities ETF
PFF
$13.3B
$640K 0.22%
20,211
+3,254
+19% +$109K
ORCL icon
74
Oracle
ORCL
$425B
$623K 0.21%
10,211
CAT icon
75
Caterpillar
CAT
$409B
$581K 0.2%
3,542

Similar funds

Boston Research & Management's Q3 2022 Portfolio in Review

As of Q3 2022, Boston Research & Management held 106 positions worth $294M, down 4.9% from $309M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 3.8%. Boston Research & Management opened no new positions and exited 4, leaving the 106-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Technology and Industrials.

  • Boston Research & Management added most to Verizon in Q3 2022, an estimated $857K increase.
  • Boston Research & Management's biggest Q3 2022 reduction was Western Union, cutting an estimated $753K.
  • Boston Research & Management fully exited WEC Energy in Q3 2022, selling an estimated $209K.
  • Boston Research & Management's ten largest holdings make up 27% of its $294M portfolio in Q3 2022.
  • Boston Research & Management opened 0 new positions and closed 4 in Q3 2022.
  • Boston Research & Management's portfolio value fell 4.9% quarter-over-quarter to $294M.

Based on Boston Research & Management's 13F filing for Q3 2022, filed 14 Nov 2022.